Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1,315
-
Total 13F shares, excl. options
-
1,293,869,876
-
Shares change
-
-90,012,539
-
Total reported value, excl. options
-
$137,734,928,602
-
Value change
-
-$9,497,208,855
-
Put/Call ratio
-
154%
-
Number of buys
-
571
-
Number of sells
-
-660
-
Price
-
$106.45
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q3 2014
1,443 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q3 2014.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,315 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,293,869,876 shares
.
Largest 10 shareholders include Capital Research Global Investors (122,275,884 shares), FMR LLC (92,715,629 shares), VANGUARD GROUP INC (79,280,967 shares), State Street Corp (62,176,203 shares), PRICE T ROWE ASSOCIATES INC /MD/ (58,913,323 shares), BlackRock Institutional Trust Company, N.A. (40,280,469 shares), Invesco Ltd. (27,457,566 shares), Capital World Investors (26,457,190 shares), Bank of New York Mellon Corp (21,930,229 shares), and JPMORGAN CHASE & CO (21,850,856 shares).
This table shows the top 1,315 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.